All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • efocipegtrutideHM15211Phase 21 trial

    Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis

  • EG-301Phase 21 trial

    Evergreen Therapeutics, Inc. · Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)

  • EG-501EG-MNTP-01Phase 21 trial

    Evergreen Therapeutics, Inc. · Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment

  • EG-70Phase 21 trial

    enGene, Inc. · Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer

  • EGEN-5784Genetically Engineered Porcine Liver, xenogeneic porcine liverPhase 21 trial

    eGenesis, INC · Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)

  • EGL-001Phase 21 trial

    Egle Therapeutics · Solid Tumor, Adult

  • EHT102Phase 21 trial

    Shanghai Euhearing Therapeutics Co., Ltd · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

  • EI-001Phase 21 trial

    Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo

  • EI-1071Phase 21 trial

    Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease

  • EIK1004-001IMP1707-001Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumors

  • EIK1005Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer

  • EIS-12656Phase 21 trial

    Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency

  • EL219Phase 21 trial

    Elion Therapeutics, Inc. · Invasive Mould Infection

  • ELE-101Phase 21 trial

    Eleusis Therapeutics · Healthy Volunteers, Major Depressive Disorder, Depression

  • ElezanumabABT-555Phase 21 trial

    AbbVie · Spinal Cord Injury (SCI)

  • ELU42Phase 21 trial

    Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound

  • ELV001Phase 21 trial

    Elevara Medicines Limited · Active Rheumatoid Arthritis

  • EMB07Phase 21 trial

    Shanghai EpimAb Biotherapeutics Co., Ltd. · Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07

  • EMP-01Phase 21 trial

    atai Therapeutics, Inc. · Social Anxiety Disorder

  • ENA-001Phase 21 trial

    Enalare Therapeutics Inc. · Respiratory Depression

  • ENN0403Phase 21 trial

    EnnovaBio · Diabetic Macular Edema (DME)

  • ENP-501Phase 21 trial

    N-Fold, LLC · Peanut Allergy

  • enpulimabPhase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Advanced Solid Tumor

  • ENV-101taladegibPhase 21 trial

    Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease

  • ENV-501Phase 21 trial

    Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer

  • EO2463Phase 21 trial

    Enterome · Follicular Lymphoma, Marginal Zone Lymphoma

  • EP-104GIPhase 21 trial

    Eupraxia Pharmaceuticals Inc. · Eosinophilic Esophagitis

  • EP0031Phase 21 trial

    Ellipses Pharma · NSCLC

  • EP0042Phase 21 trial

    Ellipses Pharma · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes

  • EP0062Phase 21 trial

    Ellipses Pharma · Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer

  • EP0089-101Phase 21 trial

    Ellipses Pharma · Solid Cancers, Solid Tumours

  • epacadostatPhase 21 trial

    Incyte · Endometrial Cancer

  • EPI-001Phase 21 trial

    Epibiotech · Androgenetic Alopecia

  • EPI-321Phase 21 trial

    Epicrispr Biotechnologies, Inc. · Facioscapulohumeral Muscular Dystrophy

  • Eque-celFully Human BCMA Chimeric Antigen Receptor Autologous T CellPhase 21 trial

    Nanjing IASO Biotechnology Co., Ltd. · Relapsed/Refractory Multiple Myeloma

  • ER2001Phase 21 trial

    ExoRNA Bioscience · Huntington Disease

  • ERAS-0015Phase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • ERAS-601Phase 21 trial

    Erasca, Inc. · Advanced or Metastatic Solid Tumors

  • ERX1000Phase 21 trial

    ERX Pharmaceuticals · Obesity & Overweight

  • ES014Phase 21 trial

    Elpiscience (Suzhou) Biopharma, Ltd. · Desmoid Tumor

  • ES102Phase 21 trial

    Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer

  • ETD001Phase 21 trial

    Enterprise Therapeutics Ltd · Cystic Fibrosis

  • ETH47Phase 21 trial

    Ethris GmbH · Asthma (Diagnosis)

  • ETX-19477Phase 21 trial

    858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer

  • ETX-636Phase 21 trial

    Ensem Therapeutics · Advanced Solid Tumors, Advanced Breast Cancer

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • EvalstotugBA3071Phase 21 trial

    BioAtla, Inc. · Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck

  • EVER001Phase 21 trial

    Everest Medicines (China) Co.,Ltd. · Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)

  • EvexomostatSDX-7320Phase 21 trial

    SynDevRx, Inc. · HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer

  • EVM14Phase 21 trial

    Everest Medicines (Beijing) Co., Ltd. · Selected Types of Solid Tumor

NewerPage 52 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.